FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

Pragmatica-Lung Study Launches

The National Cancer Institute helps launch the Pragmatica-Lung Study as part of an effort with FDA to modernize clinical trials.

latest-news-card-1
Human Drugs

Omega Packaging CGMP Violations

FDA warns Totowa, NJ-based Omega Packaging Corp. about CGMP violations in its production of drugs as a contract facility.

latest-news-card-1
Medical Devices

Class 3 Device Changes Up Recall Risk: Study

A JAMA Network Open study from the University of Missouri-Kansas City finds a relationship between Class 3 medical device supplements and device recal...

latest-news-card-1
Human Drugs

Vanda Wants Teva Generic Hetlioz Pulled

Vanda Pharmaceuticals asks FDA to revoke its approval of a Teva ANDA for a generic form of Vandas sleep drug Hetlioz and recall the product.

latest-news-card-1
Human Drugs

Transdermal Irritation/Sensitization Assessment

FDA publishes two updated draft guidances with current information on aspects of drug transdermal and topical delivery systems to promote the developm...

latest-news-card-1
Human Drugs

Both Sides Argue Over Jurisdiction in Abortion Case

In two appellate briefs, plaintiffs and defendants argue over jurisdiction issues in their legal fight involving the abortion drug mifepristone (Mifep...

latest-news-card-1
Medical Devices

Safety Alert on O&M N95 Respirators

An FDA safety alert warns against the use of certain surgical N95 respirators manufactured by O&M Halyard due to protection failures.

latest-news-card-1
Human Drugs

Avation Medical Bladder Control Device Cleared

FDA clears an Avation Medical 510(k) for Vivally, a bladder control therapy device and mobile application for treating patients with urinary urgency a...

latest-news-card-1
Human Drugs

Clinical Trial Monitoring Q & A Guide

FDA posts a draft guidance entitled A Risk-Based Approach to Monitoring of Clinical Investigations Questions and Answers.

latest-news-card-1
Human Drugs

Partial Hold on Molecular Templates Study

FDA places a partial clinical hold on a Molecular Templates Phase 1 study of MT-0169 based on previously disclosed cardiac adverse events in two patie...